title: Comment on Publications from OpT2mise Study.
authors.forename: Tatjana
authors.initials: T
authors.lastname: Milenkovic
authors.forename: Mirjana
authors.initials: M
authors.lastname: Kocova
authors.forename: Brankica
authors.initials: B
authors.lastname: Krstevska
authors.forename: Gordana
authors.initials: G
authors.lastname: Pemovska
authors.forename: Ivica
authors.initials: I
authors.lastname: Smokovski
mesh_terms: D003922:Diabetes Mellitus, Type 1 / Q000175:diagnosis / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000208:ethnology; D003951:Diagnostic Errors; D016903:Drug Monitoring / Q000941:ethics / Q000592:standards; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D007279:Injections, Subcutaneous / Q000295:instrumentation; D007328:Insulin / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D007332:Insulin Infusion Systems / Q000009:adverse effects; D018579:Patient Selection / Q000941:ethics; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic / Q000941:ethics / Q000592:standards; D018843:Republic of North Macedonia / Q000453:epidemiology; D012306:Risk; D012959:Socioeconomic Factors
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin